Summary
To clarify the significance of the expression of pyrimidine nucleoside phosphorylase (PyNPase) mRNA as a predictive factor for the prognosis of patients with oesophageal carcinoma, the PyNPase mRNA in the tumours and normal tissues from 55 resected cases of oesophageal carcinoma was examined by a reverse transcription polymerase chain reaction (RT-PCR). As a result, a positive correlation was observed between the tumour/normal (T/N) ratio of the expression of PyNPase mRNA by RT-PCR and that of the enzyme activity of PyNPase based on the findings of an enzyme linked immunosolvent assay (r = 0.594, P = 0.009). The T/N ratio of the expression of PyNPase mRNA was significantly higher in the cases with lymph vessel invasion (P = 0.013), lymph node metastasis (P = 0.0016), and an advanced stage of the disease (P = 0.021) than those without these factors. The patients with a higher T/N ratio of PyNPase mRNA showed significantly worse prognosis than those with a lower T/N ratio (P = 0.023 with log-rank tests). A multivariate analysis for the cumulative survival rates revealed that a high T/N ratio of the expression of PyNPase mRNA was independently related to a poor prognosis. These findings suggested that the determination of PyNPase mRNA by RT-PCR thus appears to be a new useful parameter for identifying both a poor prognosis and a highly malignant potential of oesophageal carcinoma.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Chomczynski, P. & Sacci, N. (1987). Single-step method of RNA isolation by acid guanidium thiocyanate–phenol chloroform extraction. Anal Biochem 162: 156–159.
Cox, D. R. (1972). Regression models and life tables. J R Stat Ser B 34: 187–220.
Eda, H., Fujimoto, K., Watanabe, S., Ura, M., Hino, A., Tanaka, Y., Wada, K. & Ishitsuka, H. (1993). Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 32: 333–338.
Furukawa, T., Yoshimura, A., Sumizawa, T., Haraguchi, M. & Akiyama, S. (1992). Angiogenic factor. Nature 356: 668
Giatromanolaki, A., Koukourakis, M. I., Comley, M., Kaklamanis, L., Turley, H., O’Byrne, K., Harris, A. L. & Gatter, K. C. (1997). Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer. J Pathol 181: 196–199.
Hirokoshi, T., Danenberg, K. D., Stadbauer, T. H. W., Volkenandt, M., Shea, L. C. C., Aigner, K., Gustavsson, B., Leichman, L., Frosing, R., Ray, M., Gibson, N. W., Spears, C. P. & Dannanberg, P. V. (1992). Quantitation of thymidylate synthetase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res 52: 108–116.
Imazono, Y., Takebayoshi, Y., Nishiyama, K., Akiba, S., Miyadera, K., Yamada, Y., Akiyama, S. & Ohi, Y. (1997). Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J Clin Oncol 15: 2570–2578.
Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W. & Helden, C. H. (1989). Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557–562.
Ishitsuka, H., Miwa, M., Takemoto, K., Fukuoka, K., Itoga, A. & Maruyama, H. B. (1980). Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5-fluorouridine. GANN 71: 112–123.
Japanese Society for Esophageal Diseases (1992). Guidelines for the Clinical and Pathological Studies on Carcinoma of the Esophagus, Kanehara: Tokyo
Kaplan, E. L. & Meier, P. (1958). Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481.
Kono, A., Hara, Y., Sugata, S., Karube, Y., Matsushima, Y. & Ishitsuka, H. (1983). Activation of 5′-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chem Pharm Bull 31: 175–178.
Kubota, Y., Miura, T., Moriyama, M., Noguchi, S., Matsuzaki, J., Takabayashi, S. & Hosaka, M. (1997). Thymidine phosphorylase activity in human bladder cancer: difference between superficial and invasive cancer. Clin Cancer Res 3: 973–976.
Luccioni, C., Beaumatin, J., Bardot, V. & Lefrancois, D. (1994). Pyrimidine nucleotide metabolism in human colon carcinomas: comparison of normal tissues, primary tumors and xenografts. Int J Cancer 58: 517–522.
Maeda, K., Chung, Y. S., Ogawa, Y., Takatsuka, S., Kang, S. M., Ogawa, M., Sawada, T., Onoda, N., Kato, Y. & Sowa, M. (1996). Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 73: 884–888.
Mimori, K., Mori, M., Shiraishi, T., Haraguchi, M., Ueo, H. & Akiyoshi, T. (1997). Clinical significance of pyrimidine nucleoside phosphorylase in colorectal carcinoma. Int J Oncol 10: 493–496.
Mori, M., Mimori, M., Inoue, H., Barnard, G. F., Tsuji, K. & Nanbara, S. (1995). Detection of cancer micrometastasis in lymph nodes by reverse transcription-polymerase chain reaction. Cancer Res 55: 3417–3420.
Mori, M., Mimori, K., Ueo, H., Karimine, N., Barnard, G. F. & Sugimachi, K. (1996). Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 68: 739–743.
Mori, M., Mimori, K., Shiraishi, T., Ueo, H., Sugimachi, K. & Akiyoshi, T. (1997). p27 expression and gastric carcinoma. Nature Med 3: 593
Nio, Y., Kimura, H., Tsubono, M., Tseng, C. C., Kawabata, K., Masai, Y., Hayashi, H., Meyer, C., Fukumoto, M. & Tobe, T. (1992). Antitumor activity of 5′-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs. Anticancer Res 12: 1141–1146.
Nishida, M., Hino, A., Matsumoto, T., Yoshikubo, T. & Ishitsuka, H. (1996). Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 19: 1407–1411.
Petro, R. & Pike, M. C. (1973). Conservation of the approximation (O–E2)/E in the logrank test for survival data on tumor incidence data. Biometrics 29: 579–584.
Sugimachi, K., Watanabe, M., Sadanaga, N., Ikebe, M., Kitamura, K., Mori, M. & Kuwano, H. (1994). Recent advances in the diagnosis and surgical treatment of patients with carcinoma of the esophagus. J Am Coll Surg 178: 363–368.
Takebayashi, Y., Akiyama, S., Akiba, S., Yamada, K., Miyadera, K., Sumizawa, T., Yamada, Y., Murata, F. & Aikou, T. (1996a). Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1110–1117.
Takebayashi, Y., Miyadera, K., Akiyama, S., Hokita, S., Yamada, K., Akiba, S., Yamada, Y., Sumizawa, T. & Aikou, T. (1996b). Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 87: 288–295.
Takebayashi, Y., Yamada, K., Miyadera, K., Sumizawa, T., Furukawa, T., Kinoshita, F., Aoki, D., Okumura, H., Yamada, Y., Akiyama, S. & Aikou, T. (1996c). The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer 32A: 1227–1232.
Tanigawa, N., Amaya, H., Matsumura, M., Katoh, Y., Kitaoka, A., Aotake, T., Shimomatsuya, T., Rosenwasser, O. A. & Iki, M. (1996). Tumor angiogenesis and expression of thymidine phosphorylase/platelet derived endothelial cell growth factor in human gastric carcinoma. Cancer Lett 108: 281–290.
Weber, G. (1983). Biochemical strategy of cancer cells and the design of chemotherapy: GHA Clowes Memorial Lecture. Cancer Res 43: 3466–3492.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Yamagata, M., Mori, M., Mimori, K. et al. Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer. Br J Cancer 79, 565–569 (1999). https://doi.org/10.1038/sj.bjc.6690089
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690089